XTalks
JULY 25, 2023
Emergent BioSolutions, a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, has achieved a significant milestone with the approval of its Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) vaccine by the US Food and Drug Administration (FDA). How Does Cyfendus Work? mL for intramuscular injection.
XTalks
FEBRUARY 21, 2022
BioNTech announced its new vaccine manufacturing approach in Africa where the company will ship modular factories, called the BioNTainer, to the continent to enable domestic production of the vaccines to help increase supplies. Related: BioNTech to Build First mRNA Vaccine Production Plant in Africa. Photo source: BioNTech.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 22, 2022
In addition, immunity against the infection is found to wane for both previously infected individuals and the vaccinated. Kai Kupferschmidt, a science journalist, shared an article on the rising measles cases worldwide. Measles is highly contagious and therefore is more visible when vaccine levels decline, the article noted.
Drug Discovery World
APRIL 25, 2024
The market for cell line development is currently rising due to an increased focus by the life sciences sector on biopharmaceuticals and targeted therapies. HEK 293 cells on the other hand are used within viral vector productions which have wide-scale applications for vaccines and therapies.
Pharmaceutical Technology
FEBRUARY 3, 2023
With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.
XTalks
MAY 20, 2022
Britain recently announced it will be offering the smallpox vaccine, which is 85 percent effective against monkeypox according to the World Health Organization (WHO) , to healthcare workers in the country due to the handfuls of cases being reported across Europe. Related: Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy.
XTalks
MAY 29, 2024
In 2023, Merck officially became the proud owner of the world’s best-selling drug Keytruda, which knocked Pfizer’s COVID-19 vaccine Comirnaty from the top spot. The company’s HPV vaccine Gardasil also had robust global demand in 2023, especially in China according to Merck, as well as public-sector buying patterns in the US.
Expert insights. Personalized for you.
98 
Let's personalize your content